About Us: Partnership Opportunities

With our proprietary approach, Allarity Therapeutics is at the forefront of cancer precision medicine development.

Our DRP^® platform is able to unlock the complexity of a tumor and provide a best-in-class companion diagnostic to match the right patient to the right cancer drug.

Allarity Therapeutics seeks partnering opportunities in the following areas:

• Co-development and co-funding of Phase 2 and Phase 3 clinical trials
• Creation of joint ventures to advance programs of mutual interest
• Regional or global drug development and marketing programs
• DRP^® companion diagnostic development for external drug program

Interested in partnering opportunities with Allarity? Contact us at [email protected]